Development of a global quantitative proteomics methodology and clinical applications in chronic diseases
Development of a global quantitative proteomics methodology and clinical applications in chronic diseases
Shotgun proteomics refers to the untargeted and unbiased analysis of the global proteome as this occurs in a biological system. The overarching aim of my research is to develop a proteomics methodology for the in-depth profiling of tissue and cell-lines and apply this novel methodology in mouse model and human samples in order to identify molecular mechanisms and novel therapeutic targets of obesity and obesity-related chronic diseases, including Alzheimer’s disease and oesophageal adenocarcinoma.
The innovative quantitative proteomics methodology we developed for the global, untargeted proteomic profiling of cell lines and tissue has wide applications in different subject areas of biomedical research. Depending on the samples analysed and experimental design, this methodological approach can provide novel insight into physiological processes, the pathophysiology of disease, as well as identify novel therapeutic targets and disease markers.
University of Southampton
Manousopoulou, Antigoni
4e4b92ba-be65-4dba-a15d-87924c56f08b
July 2018
Manousopoulou, Antigoni
4e4b92ba-be65-4dba-a15d-87924c56f08b
Carare, Roxana-Octavia
0478c197-b0c1-4206-acae-54e88c8f21fa
Manousopoulou, Antigoni
(2018)
Development of a global quantitative proteomics methodology and clinical applications in chronic diseases.
University of Southampton, Doctoral Thesis, 108pp.
Record type:
Thesis
(Doctoral)
Abstract
Shotgun proteomics refers to the untargeted and unbiased analysis of the global proteome as this occurs in a biological system. The overarching aim of my research is to develop a proteomics methodology for the in-depth profiling of tissue and cell-lines and apply this novel methodology in mouse model and human samples in order to identify molecular mechanisms and novel therapeutic targets of obesity and obesity-related chronic diseases, including Alzheimer’s disease and oesophageal adenocarcinoma.
The innovative quantitative proteomics methodology we developed for the global, untargeted proteomic profiling of cell lines and tissue has wide applications in different subject areas of biomedical research. Depending on the samples analysed and experimental design, this methodological approach can provide novel insight into physiological processes, the pathophysiology of disease, as well as identify novel therapeutic targets and disease markers.
Text
A. Manousopoulou PhD
- Version of Record
More information
Published date: July 2018
Identifiers
Local EPrints ID: 427726
URI: http://eprints.soton.ac.uk/id/eprint/427726
PURE UUID: abd0d869-42a2-462b-9b42-f993aa0b7a30
Catalogue record
Date deposited: 25 Jan 2019 17:30
Last modified: 16 Mar 2024 03:04
Export record
Contributors
Author:
Antigoni Manousopoulou
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
